Betalin Therapeutics Company
Betalin Therapeutics is a privately-held company. They develop a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP). The EMP is a combination of harvested pancreatic islets (also known as Islets of Langerhans) and a proprietary biological micro-environment for supporting the harvested cells.
Technology:
Biotechnology, Health Care, Wellness
Industry:
Regenerative Medicine
Headquarters:
Ramat Gan, Israel
Founded Date:
2015
Employees Number:
1-10
Funding Status:
Early Stage Venture
Register and Claim Ownership